These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3245592)

  • 41. Dissolution systems for chloramphenicol tablet bioavailability.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):712-5. PubMed ID: 37318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
    Rapaka RS; Knight PW; Prasad VK
    J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mass-balanced blend uniformity analysis of pharmaceutical powders by at-line near-infrared spectroscopy with a fiber-optic probe.
    Li W; Johnson MC; Bruce R; Ulrich S; Rasmussen H; Worosila GD
    Int J Pharm; 2006 Dec; 326(1-2):182-5. PubMed ID: 16920283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of melatonin in pharmaceutical formulations and human plasma by gas chromatography-electron impact mass spectrometry.
    Covaci A; Doneanu C; Aboul-Enein HY; Schepens P
    Biomed Chromatogr; 1999 Oct; 13(6):431-6. PubMed ID: 10477902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets: quality attributes and experimental variables contributing to dissolution variance.
    Deng G; Ashley AJ; Brown WE; Eaton JW; Hauck WW; Kikwai LC; Liddell MR; Manning RG; Munoz JM; Nithyanandan P; Glasgow MJ; Stippler E; Wahab SZ; Williams RL
    Pharm Res; 2008 May; 25(5):1100-9. PubMed ID: 18172581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multivariate calibration of energy-dispersive X-ray diffraction data for predicting the composition of pharmaceutical tablets in packaging.
    Crews C; Kenny PS; O'Flynn D; Speller RD
    J Pharm Biomed Anal; 2018 Mar; 151():186-193. PubMed ID: 29353807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of mefenamic acid polymorphs in commercial tablets using chemometric coupled to MIR and NIR spectroscopies. Prediction of dissolution performance.
    Antonio M; Maggio RM
    J Pharm Biomed Anal; 2018 Feb; 149():603-611. PubMed ID: 29202439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The real-time FOCSDT detection method and conditions for dissolution test of metronidazole and vitamin B6 tablets].
    Wu J; Yang M; Li XX; Chen J
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Sep; 26(9):1761-4. PubMed ID: 17112065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):708-12. PubMed ID: 458569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interpretation of dissolution rate data from in vitro testing of compressed tablets.
    Kitazawa S; Johno I; Minouchi T; Okada J
    J Pharm Pharmacol; 1977 Aug; 29(8):453-9. PubMed ID: 19592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemometric and derivative methods as flexible spectrophotometric approaches for dissolution and assaying tests in multicomponent tablets.
    Markopoulou CK; Malliou ET; Koundourellis JE
    Farmaco; 2004 Aug; 59(8):627-36. PubMed ID: 15262532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-tablet assays. Automated assay of single tablets of isoxsuprine hydrochloride.
    Bryant R; Mantle DE; Timma DL; Yoder DS
    J Pharm Sci; 1968 Apr; 57(4):658-60. PubMed ID: 5652160
    [No Abstract]   [Full Text] [Related]  

  • 54. Design and evaluation of an automated system for in vitro dissolution testing utilizing a high-pressure liquid chromatographic multiport switching valve.
    Kent JS; Wong PP; Hegde GP
    J Pharm Sci; 1977 Dec; 66(12):1665-70. PubMed ID: 925926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. III. TABLET LUBRICANTS.
    LEVY G; GUMTOW RH
    J Pharm Sci; 1963 Dec; 52():1139-44. PubMed ID: 14088962
    [No Abstract]   [Full Text] [Related]  

  • 56. Continuous flow apparatus for the determination of the dissolution characteristics of tablets and capsules.
    Pernarowski M; Woo W; Searl RO
    J Pharm Sci; 1968 Aug; 57(8):1419-21. PubMed ID: 5677352
    [No Abstract]   [Full Text] [Related]  

  • 57. Chemoinformetrical evaluation of dissolution property of indomethacin tablets by near-infrared spectroscopy.
    Otsuka M; Tanabe H; Osaki K; Otsuka K; Ozaki Y
    J Pharm Sci; 2007 Apr; 96(4):788-801. PubMed ID: 17238202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EFFECT OF CERTAIN TABLET FORMULATION FACTORS ON DISSOLUTION RATE OF THE ACTIVE INGREDIENT. I. IMPORTANCE OF USING APPROPRIATE AGITATION INTENSITIES FOR IN VITRO DISSOLUTION RATE MEASUREMENTS TO REFLECT IN VIVO CONDITIONS.
    LEVY G
    J Pharm Sci; 1963 Nov; 52():1039-46. PubMed ID: 14079628
    [No Abstract]   [Full Text] [Related]  

  • 59. Automated drug dissolution monitor that uses a UV-visible diode array spectrophotometer.
    Lo SC; Donahue SM; Brown CW
    J Pharm Sci; 1993 Apr; 82(4):350-4. PubMed ID: 8468676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Submicrometer intracellular chemical optical fiber sensors.
    Tan W; Shi ZY; Smith S; Birnbaum D; Kopelman R
    Science; 1992 Oct; 258(5083):778-81. PubMed ID: 1439785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.